SINGAPORE AUGUST 05, 2016

myHealth Sentinel (mHS), an industry-leading Healthcare Connectivity Solutions (HCS) company, is delighted to announce its partnership with Enovacom, a leading software vendor in interoperability and security solutions in healthcare environment, to introduce its suite of advanced software-based solutions into the SE Asia hospital IT marketplace.

Enovacom’s advanced ‘Integration Engine Technology’ – based on its core solution ENOVACOM Suite – enables the secure, seamless sharing of information between new and legacy healthcare IT systems, which is essential to the creation and scaling-up of the extended medical ecosystems, required to meet the soaring demand for long term chronic care.

Enovacom’s interoperability solutions are cost-effective and can be implemented in months rather than years, providing rapid improvements in operating efficiency and ROI. To date, Enovacom’s solutions have been deployed in over 1500 sites in Europe and North America, integrating hundreds of mission-critical healthcare applications.

“mHS is a leader in providing best-of-breed Healthcare Connectivity Solutions”, said Mr. William Chew, Managing Director and co-founder of myHealth Sentinel. “Together with our award-winning solutions encompassing Telehealth, Medical Device Integration & Lab Middleware, the addition of Enovacom’s solutions will offer our growing base of customers, the ability to quickly and economically interconnect their silo’ed systems throughout their expanding IT ecosystem.”
“After Europe and North America, we now are proud to settle in South East Asia partnering with a recognized healthcare player that will help us deploy and support our solutions locally. The combination of both our expertise is a plus for the challenges that the healthcare IT Market has to face daily and we’re confident that the success encountered in other parts of the world should happen soon here too,” emphasizes Laurent Frigara, co-founder and CEO of Enovacom.

About myHealth Sentinel:
mHS is a young and fast-growing Singapore-based HealthTech company focused on providing industry-leading Healthcare Connectivity Solutions (HCS), which interconnect clinicians, patients and IT systems with patient data across the healthcare ecosystem. The mHS team is helmed by seasoned technology professionals with several decades of proven management experience.
More details of mHS can be found at http://www.myhealthsentinel.com.

About Enovacom:
Enovacom provides healthcare organisations and care providers with interoperable data integration and security solutions. Based on its strong heritage, and understanding of the challenges and regulatory demands within healthcare, Enovacom technology can create integrated environments that enable the efficient and safe sharing of information between healthcare professionals and across care organisations. With over 1500 customers worldwide, partnerships with major ehealth players, Enovacom is now present in France, Belgium and Switzerland, UK, Canada and Singapore.
More details about Enovacom can be found at http://www.enovacom.com

myHealth Sentinel Pte Ltd (mHS), a leading cloud-based Telehealth Service Provider, is delighted to announce that it has been appointed as the exclusive distributor in Singapore, for the range of innovative, contact-free, continuous monitoring solutions developed by “EarlySense.”

SINGAPORE, SOUTH EAST ASIA (PRWEB) JULY 25, 2016

myHealth Sentinel Pte Ltd (mHS), a leading cloud-based Telehealth Service Provider, is delighted to announce that it has been appointed as the exclusive distributor in Singapore, for the range of innovative, contact-free, continuous monitoring solutions developed by “EarlySense.”

EarlySense’s contactless monitoring solution consists of a proprietary, pressure sensitive sensor placed under a patient’s bed mattress, which continuously measures the minute vibrations produced by the patient’s heart rate, respiration and movement. This continuous stream of data is analyzed by advanced mathematical algorithms, which provides clinicians with advance warning of patient health deterioration as well as potential fall situations when the patient is attempting to exit the bed. The EarlySense products have been deployed in over 1,700 hospital beds globally and have received FDA, CE and HSA approval.

mHS’ “TeleMetrix+” (TM+) is the first commercial telehealth service to be clinically approved by a major Singapore public hospital for mainstream deployment to outpatients suffering from chronic conditions such as hypertension, diabetes and heart failure. Since 2014, TM+ has been successfully deployed by a number of major Singapore public hospitals to over 1500 outpatients for remote monitoring of their blood pressure, blood glucose and body weight.

“Singapore is renowned as a regional center of healthcare excellence, and is a key market for our solution,” said Yfat Scialom, VP, International Sales and Marketing at EarlySense. “We are pleased to collaborate with mHS and leverage its local expertise to bring our clinically-proven technology to medical facilities across the region.”

“We are delighted to be selected by EarlySense as its Singapore partner,” said Mr. William Chew, Managing Director and co-founder of myHealth Sentinel. “EarlySense’s monitoring technology is an ideal match for our suite of healthcare solutions, and together we can empower clinicians to provide enhanced levels of proactive care both within the hospitals as well as in patients’ homes.”

SINGAPORE JULY 05, 2016

myHealth Sentinel Launches the First Telehealth Big Data Analytics – myQ Decision Support

myHealth Sentinel (mHS), a leading cloud-based Telehealth Service Provider, is delighted to announce the launch of its Telehealth analytic product “myQ Decision Support”. This is the result of a partnership with “QSpectral Systems an Australian based data science company delivering innovative analytics for industry.

“myQ Decision Support” (mQDS) is being offered as a value-added option for mHS’ “TeleMetrix+” (TM+) telehealth service. mQDS enables clinicians to leverage machine learning and AI-powered analytics to the biometric data being collected by TM+. This will permit more comprehensive clinical insights to better tailor, management and provide predictive indicators for patients at risk for early intervention.
Implementation of mQDS involves the development of custom analytic models designed to determine the probability of specific clinical outcomes and rank their urgency. TM+ data, together with multiple other sources of patient clinical data can be blended to enhance the predictive accuracy of the mQDS analytic models.
“mQDS is the next step-up the value chain for our growing base of clients” said Mr. William Chew, Managing Director and co-founder of myHealth Sentinel, “by enabling them to derive actionable clinical insights from the valuable body of data being generated by our TM+ services.

About myHealth Sentinel:
mHS is a young and fast-growing Singapore-based HealthTech company focused on providing industry-leading Healthcare Connectivity Solutions (HCS), which interconnect clinicians, patients and IT systems with patient data across the healthcare ecosystem. The mHS team is helmed by seasoned technology professionals with several decades of proven management experience.
More details of mHS can be found at http://www.myhealthsentinel.com.

About QSpectral:
QSpectral is a data science company, specialising in providing strategy and intelligence through mathematical modelling, data science and analytics. Our multi-disciplinary company comprises of research, data science and clinical expertise and ongoing collaborations with major universities. This unique team enables us to provide meaningful and innovative solutions for healthcare.
More details about QSpectral can be found at http://www.qspectral.com.au

EarlySense Targets Growth in Southeast Asia with New Distributor
Partnership with MyHealth Sentinel Strengthens EarlySense’s Global Reach

Ramat Gan, Israel, March 22, 2016 – EarlySense, the market leader in contact-free monitoring solutions, today announced it has signed a distribution agreement with myHealth Sentinel (mHS), a company focused on providing industry-leading Healthcare Connectivity Solutions for hospitals in Singapore and Southeast Asia.

“We are delighted to be selected by EarlySense as its Singapore partner,” said Mr. William Chew, Managing Director and co-founder of myHealth Sentinel. “EarlySense’s monitoring technology is an ideal match for our suite of healthcare solutions, and together we can empower hospitals to provide enhanced levels of proactive care.”

To boost your winnings you merely have to play the Lucky Lady’s Charm Slot . Each fun-filled game is full of exciting musical soundtracks and the newest graphics while you attempt to hit the jackpot. Another important thing about free slot games is they supply you with a trial edition of the game before you opt to commit with real money. If you want to get more information, you should visit lucky lady charm kostenlos spielen. Great for people who wish to play their favourite slot games online with no kind of hassle, online casinos that offer absolutely free slots no download games do not need players to register or download any type of software onto their PC.

After the game starts you have to select a sum of Twists. It’s an exciting game that provides a chance to players to win more prices. By this time, you should already know that you could easily enjoy the finest free casino slots games without downloads at no charge to you.

Slot machines are popular all over the world! Lucky Lady’s Charm Slot Machine is still another Novomatic slot that I have added to the list of completely free slots which we’ve got on the website. TheLucky Lady’s Charm Deluxe slot machine is a favorite slot here in the united kingdom and not only for the ladies.

EarlySense’s Singapore Health Sciences Authority (HSA) registered system enables continuous, contact-free monitoring of patients’ heart and respiration rates and movement. It is clinically proven to assist in early detection of patient deterioration and helping to prevent adverse events.

The partnership is an important component of EarlySense’s strategy to expand its global reach and will help solidify the company’s impact in Southeast Asia.

“Singapore is renowned as a regional center of healthcare excellence, and is a key market for our solution,” said Yfat Scialom, VP, International Sales and Marketing at EarlySense. “We are pleased to collaborate with mHS and leverage its local expertise to bring our clinically-proven technology to medical facilities across the region.”

About EarlySense
EarlySense provides contact-free, continuous monitoring solutions for the medical and consumer digital health markets. EarlySense’s patented sensor and advanced algorithms monitor and analyze cardiac, respiratory, sleep and motion parameters. Used in hospitals and healthcare facilities worldwide, EarlySense assists clinicians in early detection of patient deterioration, helping to prevent adverse events, including code blues, preventable ICU transfers, patient falls and pressure ulcers.

The myEarlySense smart home-compatible consumer solution brings hospital-proven technology to the home, providing valuable data regarding wellness and sleep. myEarlySense OEM technology is at the core of wellness and sleep products marketed by international partners including Samsung, Beurer and iFit. EarlySense was founded in 2004 and has offices in Waltham, MA and Ramat Gan, Israel. For more information, please visit www.EarlySense.com and www.myEarlySense.com.

About myHealth Sentinel:
mHS is a Singapore-based IT company focused on providing industry-leading ‘Healthcare Connectivity Solutions’ (HCS) which interconnect and harmonize sources of patient data from across the healthcare ecosystem with ‘Hospital Information Systems’ (HIS) and ‘Electronic Medical Records’ (EMR’s). The mHS team is helmed by seasoned technology professionals with decades of proven management experience. More information on mHS can be found at www.myhealthsentinel.com.